IP Library Granted Patent US 9,029,393
Granted Patent B2
US 9,029,393 · App. 13/146,327 · Granted May 12, 2015

Adenosine receptor ligands and uses thereof

Inventors: Stephan Schann (Graffenstaden, FR); Stanislas Mayer (Eschau, FR)
Assignee: Kaldi Pharma, SAS
C07D487/04C07D471/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,029,393
App. No.
13/146,327
Granted
May 12, 2015
Kind
B2
Abstract

The present invention provides new compounds with high affinity for adenosine A 2A receptors. It also provides antagonists of adenosine A 2A receptors and their use as medicaments for the treatment and/or prophylaxis of diseases and disorders where the partial or total inactivation of adenosine A 2A receptors signalling pathways could be beneficial such as Alzheimer's disease, Parkinson's disease, attention deficit and hyperactivity disorders (ADHD), Huntington's disease, neuroprotection, schizophrenia, anxiety and pain. The present invention further relates to pharmaceutical compositions containing such new compounds with high affinity for adenosine A 2A receptors and their use for the treatment and/or prophylaxis of diseases and disorders where the partial or total inactivation of adenosine A 2A receptors could be beneficial.

Claims (473)

1. A compound selected from the group consisting of:

(a) a compound of general formula (I) as follows:

wherein:

R 1 and R 2 are independently selected from alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heteroaryl or heterocycloalkyl, or R 1 and R 2 , together with the nitrogen atom they are attached to, form a heterocycloalkyl ring or a heteroaryl ring;

Y 1 , Y 2 , Y 3 and Y 4 are independently selected from CH, CR 3 , or N;

R 3 is selected from lower alkyl, cycloalkyl, O-(lower alkyl), S-(lower alkyl), NH 2 , NH-(lower alkyl), N-(lower alkyl)(lower alkyl), halogen, CF 3 or CN;

R 4 is selected from hydrogen, lower alkyl, cycloalkyl, O-(lower alkyl), S-(lower alkyl), NH 2 , NH-(lower alkyl), N-(lower alkyl)(lower alkyl), halogen, CF 3 or CN;

A represents a heterocyclic group selected from:

with

* being the position linked to the heterocyclic moiety comprising Y 1 , Y 2 , Y 3 and Y 4 in Formula (I) and *″ being the position linked to the carbonyl group in Formula (I);

R 5 being selected from hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, (CH 2 ) 2 —O—(CH 2 ) 2 —O—CH 3 , CO-alkyl, CO-aryl, CO-heterocycloalkyl, CO-cycloalkyl, CO-heteroaryl, SO 2 -alkyl, SO 2 -aryl, SO 2 -heterocycloalkyl, SO 2 -cycloalkyl or SO 2 -heteroaryl;

R 6 being selected from hydrogen, lower alkyl, halogen, OH, O-(lower alkyl), NH 2 , NH-(lower alkyl), N(lower alkyl)(lower alkyl) or heterocycloalkyl;

X 1 , X 2 , X 3 and X 4 each representing CH, CR 7 or N; and

R 7 being selected from hydrogen, lower alkyl, O-(lower alkyl), NH-(lower alkyl), N-(lower alkyl) (lower alkyl), halogen, NO 2 , NH 2 , NH—OH, OH, or CN;

or a pharmaceutically acceptable salt thereof; and

(b) a compound of general formula (I) as follows:

wherein:

R 1 and R 2 are independently selected from alkyl, alkenyl, alkynyl, aryl, or cycloalkyl, or R 1 and R 2 , together with the nitrogen atom they are attached to, form a heterocycloalkyl ring or a heteroaryl ring;

Y 1 , Y 2 , Y 3 and Y 4 are independently selected from CH, CR 3 , or N;

R 3 is selected from lower alkyl, cycloalkyl, O-(lower alkyl), S-(lower alkyl), NH 2 , NH-(lower alkyl), N-(lower alkyl)(lower alkyl), halogen, CF 3 or CN;

R 4 is selected from hydrogen, lower alkyl, cycloalkyl, O-(lower alkyl), S-(lower alkyl), NH 2 , NH-(lower alkyl), N-(lower alkyl)(lower alkyl), halogen, CF 3 or CN;

A represents a heterocyclic group A11:

with

* being the position linked to the heterocyclic moiety comprising Y 1 , Y 2 , Y 3 and Y 4 in Formula (I) and *″ being the position linked to the carbonyl group in Formula (I);

R 5 being selected from hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, (CH 2 ) 2 —O—(CH 2 ) 2 —O—CH 3 , CO-alkyl, CO-aryl, CO-heterocycloalkyl, CO-cycloalkyl, CO-heteroaryl, SO 2 -alkyl, SO 2 -aryl, SO 2 -heterocycloalkyl, SO 2 -cycloalkyl or SO 2 -heteroaryl;

R 6 being selected from hydrogen, lower alkyl, halogen, OH, O-(lower alkyl), NH 2 , NH-(lower alkyl), N(lower alkyl)(lower alkyl) or heterocycloalkyl;

X 1 , X 2 , X 3 and X 4 each representing CH, CR 7 or N; and

R 7 being selected from hydrogen, lower alkyl, O-(lower alkyl), NH-(lower alkyl), N-(lower alkyl) (lower alkyl), halogen, NO 2 , NH 2 , NH—OH, OH, or CN;

or a pharmaceutically acceptable salt thereof.

2. The compound according to claim 1 or a pharmaceutically acceptable salt thereof wherein A represents a heterocyclic group selected from A1 to A8.

3. The compound according to claim 1 or a pharmaceutically acceptable salt thereof wherein A represents a heterocyclic group selected from A1 to A4.

4. The compound according to claim 1 or a pharmaceutically acceptable salt thereof wherein A represents a heterocyclic group selected from A1 or A2.

5. The compound according to claim 1 or a pharmaceutically acceptable salt thereof wherein A represents a heterocyclic group being A2.

6. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein not more than one of Y 1 , Y 2 , Y 3 , and Y 4 is N and the others are independently selected from CH or CR 3 .

7. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein R 1 and R 2 are independently selected from C 1-10 -alkyl, C 6-10 -aryl, or C 3-10 -cycloalkyl, or R 1 and R 2 , together with the nitrogen atom they are attached to, form a heterocycloalkyl ring having 5 to 10 ring atoms of which one, two or three are heteroatoms.

8. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein R 4 is selected from hydrogen or lower alkyl.

9. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein R 3 is selected from fluorine or CN.

10. The compound according to claim 1 , wherein the compound is selected from the group consisting of:

4-(8-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-ethyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(7-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methoxy-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(2-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-[4-(Azepane-1-carbonyl)-benzoyl]-imidazo[1,2-a]pyridine-6-carbonitrile;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methoxy-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-chloro-benzamide;

3-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-3-fluoro-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-nitro-benzamide;

N-Cyclohexyl-N-ethyl-6-(imidazo[1,2-a]pyridine-3-carbonyl)-nicotinamide;

2-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-(6,8-dichloro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-fluoro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-nitro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-hydroxyamino-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[2-Amino-4-(azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-Amino-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-chloroimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-methylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl][6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-ethylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-cyclopropylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](imidazo[1,2-a]pyridin-3-yl)methanone;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-propyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-prop-2-ynyl-benzamide;

N-Cyclohexyl-N-cyclopropylmethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Allyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-(2,2,2-trifluoro-ethyl)-benzamide;

N-Cyclohexyl-N-(2-dimethylamino-ethyl)-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Butyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N,N-Dicyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-(4-methoxy-phenyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-p-tolyl-benzamide;

N-(4-Chloro-phenyl)-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-2-yl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-4-yl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-phenyl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-pyridin-3-yl-benzamide;

N,N-Diethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dimethyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dipropyl-benzamide;

Imidazo[1,2-a]pyridin-3-yl-[4-(pyrrolidine-1-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(piperidine-1-carbonyl)-phenyl]-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azocane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azonane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(morpholine-4-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(4-methyl-piperazine-1-carbonyl)-phenyl]-methanone;

[4-(2,3-Dihydro-indole-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(2-methyl-2,3-dihydro-indole-1-carbonyl)-phenyl]-methanone;

[4-(3,4-Dihydro-2H-quinoline-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(octahydro-quinoline-1-carbonyl)-phenyl]-methanone;

3-[4-(Azepan-1-ylcarbonyl)-2-fluorobenzoyl]imidazo[1,2-a]pyridine-6-carbonitrile;

4-[(6-Fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N,N-diisopropylbenzamide;

N-Ethyl-3-fluoro-4-[(6-fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N-isopropylbenzamide;

(6-Fluoroimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-hydroxy-ethyl)-1H-indazol-6-yl]-methanone;

[6-(Azepan-1-ylcarbonyl)]-1-ethyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isopropyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isobutyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-[6-(Azepan-1-ylcarbonyl)-1-methyl-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-(trifluoromethyl)-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-chloro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-methyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-ethyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-cyclopropyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-bromo-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-N,1-dimethyl-N-phenyl-1H-indazole-6-carboxamide;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1-methyl-1H-indazole-6-carboxamide;

[3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-(decahydroquinolin-1-yl)-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-carboxylic acid cyclohexyl-cyclopropyl-methyl-amide;

Azonan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azocan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-6-(piperidin-1-ylcarbonyl)-1H-indazole;

3-[1-Methyl-6-(piperidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[1-Methyl-6-(pyrrolidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2R)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2S)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Aza-bicyclo[3.2.1]octane-8-carbonyl)-1-methyl-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

3-{1-Methyl-6-[(4-methylpiperazin-1-yl)carbonyl]}-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(6-Cyano-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazole-6-carboxylic acid diisopropylamide;

2-Methyl-3-[1-Methyl-6-(azepan-1-ylcarbonyl)-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

Azepan-1-yl-[1-benzyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-phenethyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[2-(2-methoxyethoxyl)ethyl]-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-morpholin-4-yl-ethyl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[(4-methylpiperazin-1-yl)carbonyl]-1H-indazol-6-yl]-methanone;

3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazol-6-yl]-methanone;

[4-(Azepan-1-ylcarbonyl)-2-hydroxyphenyl](6-fluoroimidazo[1,2-a]pyridin-3-yl)methanone;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1,2-benzisoxazole-6-carboxamide;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

6-(Azepan-1-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(morpholin-4-ylcarbonyl)phenyl]methanone;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(morpholin-4-ylcarbonyl)-1,2-benzisoxazole;

[4-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

3-[6-(Piperidin-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Azepan-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Morpholin-4-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

Imidazo[1,2-a]pyridine-3-carboxylic acid [4-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

Imidazo[1,2-a]pyridine-3-carboxylic acid [5-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-5-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[c]isoxazol-6-yl]-methanone;

5-(Azepan-1-ylcarbonyl)-1-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-1H-1,2,3-benzotriazole;

Azepan-1-yl-[1-benzenesulfonyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indol-6-yl]-methanone;

3-[6-(Azepan-1-ylcarbonyl)-1H-indol-3-yl]-6-fluoroimidazo[1,2-a]pyridine;

Azepan-1-yl-[4-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-quinazolin-7-yl]-methanone;

2-Amino-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

2-Methyl-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyrimidin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-chloroimidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide; and

a pharmaceutically acceptable salt thereof.

11. A pharmaceutical composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable excipient and/or carrier.

12. A medicament comprising the compound of formula (I) according to claim 1 or a pharmaceutically acceptable salt thereof.

13. The pharmaceutical composition according to claim 11 , wherein the compound is selected from the group consisting of:

4-(8-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-ethyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(7-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methoxy-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(2-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-[4-(Azepane-1-carbonyl)-benzoyl]-imidazo[1,2-a]pyridine-6-carbonitrile;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methoxy-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-chloro-benzamide;

3-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-3-fluoro-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-nitro-benzamide;

N-Cyclohexyl-N-ethyl-6-(imidazo[1,2-a]pyridine-3-carbonyl)-nicotinamide;

2-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-(6,8-dichloro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-fluoro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-nitro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-hydroxyamino-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[2-Amino-4-(azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-Amino-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-chloroimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-methylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl][6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-ethylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-cyclopropylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](imidazo[1,2-a]pyridin-3-yl)methanone;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-propyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-prop-2-ynyl-benzamide;

N-Cyclohexyl-N-cyclopropylmethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Allyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-(2,2,2-trifluoro-ethyl)-benzamide;

N-Cyclohexyl-N-(2-dimethylamino-ethyl)-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Butyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N,N-Dicyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-(4-methoxy-phenyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-p-tolyl-benzamide;

N-(4-Chloro-phenyl)-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-2-yl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-4-yl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-phenyl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-pyridin-3-yl-benzamide;

N,N-Diethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dimethyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dipropyl-benzamide;

Imidazo[1,2-a]pyridin-3-yl-[4-(pyrrolidine-1-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(piperidine-1-carbonyl)-phenyl]-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azocane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azonane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(morpholine-4-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(4-methyl-piperazine-1-carbonyl)-phenyl]-methanone;

[4-(2,3-Dihydro-indole-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(2-methyl-2,3-dihydro-indole-1-carbonyl)-phenyl]-methanone;

[4-(3,4-Dihydro-2H-quinoline-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(octahydro-quinoline-1-carbonyl)-phenyl]-methanone;

3-[4-(Azepan-1-ylcarbonyl)-2-fluorobenzoyl]imidazo[1,2-a]pyridine-6-carbonitrile;

4-[(6-Fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N,N-diisopropylbenzamide;

N-Ethyl-3-fluoro-4-[(6-fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N-isopropylbenzamide;

(6-Fluoroimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-hydroxy-ethyl)-1H-indazol-6-yl]-methanone;

[6-(Azepan-1-ylcarbonyl)]-1-ethyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isopropyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isobutyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-[6-(Azepan-1-ylcarbonyl)-1-methyl-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-(trifluoromethyl)-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-chloro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-methyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-ethyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-cyclopropyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-bromo-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-N,1-dimethyl-N-phenyl-1H-indazole-6-carboxamide;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1-methyl-1H-indazole-6-carboxamide;

[3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-(decahydroquinolin-1-yl)-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-carboxylic acid cyclohexyl-cyclopropyl-methyl-amide;

Azonan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azocan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-6-(piperidin-1-ylcarbonyl)-1H-indazole;

3-[1-Methyl-6-(piperidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[1-Methyl-6-(pyrrolidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2R)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2S)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Aza-bicyclo[3.2.1]octane-8-carbonyl)-1-methyl-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

3-{1-Methyl-6-[(4-methylpiperazin-1-yl)carbonyl]}-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(6-Cyano-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazole-6-carboxylic acid diisopropylamide;

2-Methyl-3[1-Methyl-6-(azepan-1-ylcarbonyl)-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

Azepan-1-yl-[1-benzyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-phenethyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[2-(2-methoxyethoxyl)ethyl]-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-morpholin-4-yl-ethyl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[(4-methylpiperazin-1-yl)carbonyl]-1H-indazol-6-yl]-methanone;

3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazol-6-yl]-methanone;

[4-(Azepan-1-ylcarbonyl)-2-hydroxyphenyl](6-fluoroimidazo[1,2-a]pyridin-3-yl)methanone;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1,2-benzisoxazole-6-carboxamide;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

6-(Azepan-1-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(morpholin-4-ylcarbonyl)phenyl]methanone;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(morpholin-4-ylcarbonyl)-1,2-benzisoxazole;

[4-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

3-[6-(Piperidin-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Azepan-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Morpholin-4-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

Imidazo[1,2-a]pyridine-3-carboxylic acid [4-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

Imidazo[1,2-a]pyridine-3-carboxylic acid [5-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-5-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[c]isoxazol-6-yl]-methanone;

5-(Azepan-1-ylcarbonyl)-1-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-1H-1,2,3-benzotriazole;

Azepan-1-yl-[1-benzenesulfonyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indol-6-yl]-methanone;

3-[6-(Azepan-1-ylcarbonyl)-1H-indol-3-yl]-6-fluoroimidazo[1,2-a]pyridine;

Azepan-1-yl-[4-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-quinazolin-7-yl]-methanone;

2-Amino-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

2-Methyl-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

N-Cyclohexyl-N-ethyl-4-(imidazo[1 ,2-a]pyrimidin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-chloroimidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide; and

a pharmaceutically acceptable salt thereof.

14. The medicament according to claim 12 , wherein the compound is selected from the group consisting of:

4-(8-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(7-ethyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(7-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(7-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Cyano-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Chloro-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

4-(6-Bromo-imidazo[1,2-a]pyridine-3-carbonyl)-N-cyclohexyl-N-ethyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-methoxy-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(2-methyl-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-[4-(Azepane-1-carbonyl)-benzoyl]-imidazo[1,2-a]pyridine-6-carbonitrile;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-methyl-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-methoxy-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-3-chloro-benzamide;

3-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-3-fluoro-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-3-nitro-benzamide;

N-Cyclohexyl-N-ethyl-6-(imidazo[1,2-a]pyridine-3-carbonyl)-nicotinamide;

2-Chloro-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(Azepane-1-carbonyl)-phenyl]-(6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-(6,8-dichloro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-fluoro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-nitro-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[4-(Azepane-1-carbonyl)-2-hydroxyamino-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

[2-Amino-4-(azepane-1-carbonyl)-phenyl]-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-methanone;

3-Amino-N-cyclohexyl-N-ethyl-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-chloroimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-methylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl][6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-ethylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](6-cyclopropylimidazo[1,2-a]pyridin-3-yl)methanone;

[4-(azepan-1-ylcarbonyl)-2-fluorophenyl](imidazo[1,2-a]pyridin-3-yl)methanone;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-propyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-prop-2-ynyl-benzamide;

N-Cyclohexyl-N-cyclopropylmethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Allyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-(2,2,2-trifluoro-ethyl)-benzamide;

N-Cyclohexyl-N-(2-dimethylamino-ethyl)-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Butyl-N-cyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N,N-Dicyclohexyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-phenyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-(4-methoxy-phenyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-p-tolyl-benzamide;

N-(4-Chloro-phenyl)-4-(6-fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-2-yl-benzamide;

4-(6-Fluoro-imidazo[1,2-a]pyridine-3-carbonyl)-N-methyl-N-pyridin-4-yl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-phenyl-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-pyridin-3-yl-benzamide;

N,N-Diethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-benzamide;

N-Ethyl-4-(imidazo[1,2-a]pyridine-3-carbonyl)-N-isopropyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dimethyl-benzamide;

4-(Imidazo[1,2-a]pyridine-3-carbonyl)-N,N-dipropyl-benzamide;

Imidazo[1,2-a]pyridin-3-yl-[4-(pyrrolidine-1-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(piperidine-1-carbonyl)-phenyl]-methanone;

[4-(Azepane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azocane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

[4-(Azonane-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(morpholine-4-carbonyl)-phenyl]-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(4-methyl-piperazine-1-carbonyl)-phenyl]-methanone;

[4-(2,3-Dihydro-indole-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(2-methyl-2,3-dihydro-indole-1-carbonyl)-phenyl]-methanone;

[4-(3,4-Dihydro-2H-quinoline-1-carbonyl)-phenyl]-imidazo[1,2-a]pyridin-3-yl-methanone;

Imidazo[1,2-a]pyridin-3-yl-[4-(octahydro-quinoline-1-carbonyl)-phenyl]-methanone;

3-[4-(Azepan-1-ylcarbonyl)-2-fluorobenzoyl]imidazo[1,2-a]pyridine-6-carbonitrile;

4-[(6-Fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N,N-diisopropylbenzamide;

N-Ethyl-3-fluoro-4-[(6-fluoroimidazo[1,2-a]pyridin-3-yl)carbonyl]-N-isopropylbenzamide;

(6-Fluoroimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(piperidin-1-ylcarbonyl)phenyl]methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-hydroxy-ethyl)-1H-indazol-6-yl]-methanone;

[6-(Azepan-1-ylcarbonyl)]-1-ethyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isopropyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-isobutyl-3[6-fluoro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-[6-(Azepan-1-ylcarbonyl)-1-methyl-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-(trifluoromethyl)-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-chloro-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-methyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-ethyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-cyclopropyl-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

[6-(Azepan-1-ylcarbonyl)]-1-methyl-3[6-bromo-imidazo[1,2-a]pyridin-3-yl]-1H-indazole;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-N,1-dimethyl-N-phenyl-1H-indazole-6-carboxamide;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1-methyl-1H-indazole-6-carboxamide;

[3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-(decahydroquinolin-1-yl)-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-carboxylic acid cyclohexyl-cyclopropyl-methyl-amide;

Azonan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

Azocan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazol-6-yl]-methanone;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-1-methyl-6-(piperidin-1-ylcarbonyl)-1H-indazole;

3-[1-Methyl-6-(piperidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[1-Methyl-6-(pyrrolidin-1-ylcarbonyl)-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2R)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-(1-Methyl-6-{[(2S)-2-(methoxymethyl) pyrrolidin-1-yl]carbonyl}-1H-indazol-3-yl)imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Aza-bicyclo[3.2.1]octane-8-carbonyl)-1-methyl-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

3-{1-Methyl-6-[(4-methylpiperazin-1-yl)carbonyl]}-1H-indazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-(6-Cyano-imidazo[1,2-a]pyridin-3-yl)-1-methyl-1H-indazole-6-carboxylic acid diisopropylamide;

2-Methyl-3-[1-Methyl-6-(azepan-1-ylcarbonyl)-1H-indazol-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile;

Azepan-1-yl-[1-benzyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-phenethyl-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[2-(2-methoxyethoxyl)ethyl]-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-morpholin-4-yl-ethyl)-1H-indazol-6-yl]-methanone;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-[(4-methylpiperazin-1-yl)carbonyl]-1H-indazol-6-yl]-methanone;

3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[d]isoxazol-6-yl]-methanone;

[4-(Azepan-1-ylcarbonyl)-2-hydroxyphenyl](6-fluoroimidazo[1,2-a]pyridin-3-yl)methanone;

N-Ethyl-3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-N-isopropyl-1,2-benzisoxazole-6-carboxamide;

3-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(piperidin-1-ylcarbonyl)-1,2-benzisoxazole;

6-(Azepan-1-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

(6-Bromoimidazo[1,2-a]pyridin-3-yl)[2-fluoro-4-(morpholin-4-ylcarbonyl)phenyl]methanone;

3-(6-Bromoimidazo[1,2-a]pyridin-3-yl)-6-(morpholin-4-ylcarbonyl)-1,2-benzisoxazole;

[4-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-2-fluorophenyl](6-bromoimidazo[1,2-a]pyridin-3-yl)methanone;

6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-3-(6-bromoimidazo[1,2-a]pyridin-3-yl)-1,2-benzisoxazole;

3-[6-(Piperidin-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Azepan-1-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(Morpholin-4-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

3-[6-(8-Azabicyclo[3.2.1]oct-8-ylcarbonyl)-1,2-benzisoxazol-3-yl]imidazo[1,2-a]pyridine-6-carbonitrile;

Imidazo[1,2-a]pyridine-3-carboxylic acid [4-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

Imidazo[1,2-a]pyridine-3-carboxylic acid [5-(cyclohexyl-ethyl-carbamoyl)-2-hydroxy-phenyl]-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-6-carboxylic acid cyclohexyl-ethyl-amide;

2-Imidazo[1,2-a]pyridin-3-yl-benzooxazole-5-carboxylic acid cyclohexyl-ethyl-amide;

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-benzo[c]isoxazol-6-yl]-methanone;

5-(Azepan-1-ylcarbonyl)-1-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-1H-1,2,3-benzotriazole;

Azepan-1-yl-[1-benzenesulfonyl-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1H-indol-6-yl]-methanone;

3-[6-(Azepan-1-ylcarbonyl)-1H-indol-3-yl]-6-fluoroimidazo[1,2-a]pyridine;

Azepan-1-yl-[4-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-quinazolin-7-yl]-methanone;

2-Amino-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

2-Methyl-7-(azepan-1-ylcarbonyl)-4-(6-fluoroimidazo[1,2-a]pyridin-3-yl)quinazoline;

N-Cyclohexyl-N-ethyl-4-(imidazo[1 ,2-a]pyrimidin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(6-chloroimidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide;

N-Cyclohexyl-N-ethyl-4-(imidazo[1,2-b]pyridazin-3-ylcarbonyl)-benzamide; and

a pharmaceutically acceptable salt thereof.

15. A method of administering a compound of formula (I) according to claim 1 , the method comprising administering the compound of formula (I) to a patient for the treatment of a disease or disorder selected from the group consisting of movement disorders, acute and chronic pain, affective disorders, central and peripheric nervous system degeneration disorders, schizophrenia and related psychosis, cognitive disorders, attention disorders, central nervous system injury, cerebral ischaemia, myocardial ischaemia, and muscle ischaemia.

16. The method according to claim 15 , wherein the compound of formula (I) is administered to a patient for the treatment of a disease or disorder selected from the group consisting of Parkinson's disease, Alzheimer's disease and attention-deficit hyperactivity disorder.

17. A method of administering the compound according to claim 10 , the method comprising administering the compound to a patient.

18. A method of administering the pharmaceutical composition according to claim 13 , the method comprising administering the pharmaceutical composition to a patient.

19. A method of administering the medicament according to claim 14 , the method comprising administering the medicament to a patient.

20. A method of administering the compound according to claim 10 , the method comprising administering the compound to a patient for the treatment of a disease or disorder selected from the group consisting of movement disorders, acute and chronic pain, affective disorders, central and peripheric nervous system degeneration disorders, schizophrenia and related psychosis, cognitive disorders, attention disorders, central nervous system injury, cerebral ischaemia, myocardial ischaemia, and muscle ischaemia.

21. A method of administering the pharmaceutical composition according to claim 13 , the method comprising administering the pharmaceutical composition to a patient for the treatment of a disease or disorder selected from the group consisting of movement disorders, acute and chronic pain, affective disorders, central and peripheric nervous system degeneration disorders, schizophrenia and related psychosis, cognitive disorders, attention disorders, central nervous system injury, cerebral ischaemia, myocardial ischaemia, and muscle ischaemia.

22. A method of administering the medicament according to claim 14 , the method comprising administering the medicament to a patient for the treatment of a disease or disorder selected from the group consisting of movement disorders, acute and chronic pain, affective disorders, central and peripheric nervous system degeneration disorders, schizophrenia and related psychosis, cognitive disorders, attention disorders, central nervous system injury, cerebral ischaemia, myocardial ischaemia, and muscle ischaemia.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2021
From: KALDI PHARMA, SAS
To: DOMAIN THERAPEUTICS, SA
Reel/Frame 057173/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2016
From: GARDAN, SOPHIE
To: KALDI PHARMA, SAS
Reel/Frame 040411/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2015
From: DOMAIN THERAPEUTICS, SA
To: KALDI PHARMA, SAS
Reel/Frame 035111/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2011
From: SCHANN, STEPHAN; MAYER, STANISLAS
To: DOMAIN THERAPEUTICS
Reel/Frame 026650/0659 →
Priority Claims (1)
EP 09360007 · Jan 26, 2009 · regional
Continuity (1)
Related Publication 20110288074A1 · Nov 24, 2011